Skip to main content
  • 2922 Accesses

Abstract

Extrapleural pneumonectomy (EPP) is a formidable surgical procedure performed on patients with limited life expectancy. Anesthetic management may contribute to containment of perioperative morbidity and mortality through the control of intraoperative physiologic disruptions and postoperative pain and an appreciation of the associated postoperative complications to affect early intervention. “EPP-specific” anesthetic concerns (above those for standard pneumonectomy) are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Wolf AS, Flores RM. Extrapleural pneumonectomy for pleural malignancies. Thorac Surg Clin. 2014;24:471–5.

    Article  Google Scholar 

  2. Butchart EG, Ashcroft T, Barnsley WC, Holden MP. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients. Thorax. 1976;31(1):15–24.

    Article  CAS  Google Scholar 

  3. Cao CQ, Yan TD, Bannon PG, McCaughan BC. A systematic review of extrapleural pneumonectomy for malignant pleural mesothelioma. J Thorac Oncol. 2010;5:1692–703.

    Article  Google Scholar 

  4. Burt BM, Cameron RB, Mollberg NM, Kosinski AS, Schipper PH, Shrager JB, et al. Malignant pleural mesothelioma and the Society of Thoracic Surgeons database: an analysis of surgical morbidity and mortality. J Thorac Cardiovasc Surg. 2014;148:30–5.

    Article  Google Scholar 

  5. Sugarbaker DJ, Jaklitsch MT, Bueno R, Richards W, Lukanich J, Mentzer SJ, et al. Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies. J Thorac Cardiovasc Surg. 2004;128(1):138–46.

    Article  Google Scholar 

  6. Sugarbaker DJ, Flores RM, Jaklitsch MT, Richards WG, Strauss GM, Corson JM, et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg. 1999;117(1):54–63. discussion 63-5.

    Article  CAS  Google Scholar 

  7. Tilleman TR, Richards WG, Zellos L, Johnson BE, Jaklitsch MT, Mueller J, et al. Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study. J Thorac Cardiovasc Surg. 2009;138(2):405–11.

    Article  Google Scholar 

  8. Rusch V, Baldini EH, Bueno R, De Perrot M, Flores R, Hasegawa S, et al. The role of surgical cytoreduction in the treatment of malignant pleural mesothelioma: meeting summary of the international mesothelioma interest group congress, September 11-14, 2012, Boston, Mass. J Thorac Cardiovasc Surg. 2013;145(4):909–10.

    Article  Google Scholar 

  9. Cao C, Tian D, Manganas C, Matthews P, Yan TD. Systematic review of trimodality therapy for patients with malignant pleural mesothelioma. Ann Cardiothorac Surg. 2012;1(4):428–37.

    PubMed  PubMed Central  Google Scholar 

  10. Hartigan PM, Ng JM. Anesthetic strategies for patients undergoing extrapleural pneumonectomy. Thorac Surg Clin. 2004;14(4):575–83, xi.

    Article  Google Scholar 

  11. Ng JM, Hartigan PM. Anesthetic management of patients undergoing extrapleural pneumonectomy for mesothelioma. Curr Opin Anaesthesiol. 2008;21(1):21–7.

    Article  Google Scholar 

  12. Zellos L, Christiani DC. Epidemiology, biologic behavior, and natural history of mesothelioma. Thorac Surg Clin. 2004;14(4):469–77, viii.

    Article  Google Scholar 

  13. Wagner JC, Sleggs CA, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med. 1960;17:260–71.

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Carbone M, Kratzke RA, Testa JR. The pathogenesis of mesothelioma. Semin Oncol. 2002;29(1):2–17.

    Article  CAS  Google Scholar 

  15. Teta MJ, Mink PJ, Lau E, Sceurman BK, Foster ED. US mesothelioma patterns 1973-2002: indicators of change and insights into background rates. Eur J Cancer Prev. 2008;17(6):525–34.

    Article  Google Scholar 

  16. Carroll N, Mohamed F, Sugarbaker P. Hyperthermic chemoperfusion, and postoperative chemotherapy: The National Cancer Institute and Washington hospital center experience. In: Pass H, Vogelzang N, Carbone M, editors. Malignant mesothelioma: advances in pathogenesis, diagnosis and translational therapies. New York: Springer; 2005. p. 732–54.

    Chapter  Google Scholar 

  17. Lee JM, Sugarbaker DJ. Extrapleural pneumonectomy for pleural malignancies. In: Sugarbaker DJ, Bueno R, Colson YL, Jaktlisch MT, Krasna MJ, Mentzer SJ, editors. Adult chest surgery. 2nd ed. New York: McGraw-Hill Professional; 2015. p. 998–1009.

    Google Scholar 

  18. Reilly JJ Jr. Evidence-based preoperative evaluation of candidates for thoracotomy. Chest. 1999;116(6 Suppl):S474–6.

    Article  Google Scholar 

  19. Amar D, Burt ME, Roistacher N, Reinsel RA, Ginsberg RJ, Wilson RS. Value of perioperative Doppler echocardiography in patients undergoing major lung resection. Ann Thorac Surg. 1996;61(2):516–20.

    Article  CAS  Google Scholar 

  20. Gill RR, Gerbaudo VH, Sugarbaker DJ, Hatabu H. Current trends in radiologic management of malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg. 2009;21(2):111–20.

    Article  Google Scholar 

  21. Slinger P. Update on anesthetic management for pneumonectomy. Curr Opin Anaesthesiol. 2009;22(1):31–7.

    Article  Google Scholar 

  22. Wittnich C, Trudel J, Zidulka A, Chiu RC. Misleading “pulmonary wedge pressure” after pneumonectomy: its importance in postoperative fluid therapy. Ann Thorac Surg. 1986;42(2):192–6.

    Article  CAS  Google Scholar 

  23. Brister NW, Barnette RE, Kim V, Keresztury M. Anesthetic considerations in candidates for lung volume reduction surgery. Proc Am Thorac Soc. 2008;5(4):432–7.

    Article  Google Scholar 

  24. Ballantyne JC, Carr DB, deFerranti S, Suarez T, Lau J, Chalmers TC, et al. The comparative effects of postoperative analgesic therapies on pulmonary outcome: cumulative meta-analyses of randomized, controlled trials. Anesth Analg. 1998;86(3):598–612.

    Article  CAS  Google Scholar 

  25. Beattie WS, Badner NH, Choi P. Epidural analgesia reduces postoperative myocardial infarction: a meta-analysis. Anesth Analg. 2001;93(4):853–8.

    Article  CAS  Google Scholar 

  26. Oka T, Ozawa Y, Ohkubo Y. Thoracic epidural bupivacaine attenuates supraventricular tachyarrhythmias after pulmonary resection. Anesth Analg. 2001;93(2):253–9. 1st contents page.

    CAS  PubMed  Google Scholar 

  27. Nino M, Body SC, Hartigan PM. The use of a bronchial blocker to rescue an ill-fitting double-lumen endotracheal tube. Anesth Analg. 2000;91(6):1370–1, TOC.

    Article  CAS  Google Scholar 

  28. Senturk M, Slinger P, Cohen E. Intraoperative mechanical ventilation strategies for one-lung ventilation. Best Prac Res Clin Anaesthesiol. 2015;29(3):357–69.

    Article  Google Scholar 

  29. Hurford WE, Kolker AC, Strauss HW. The use of ventilation/perfusion lung scans to predict oxygenation during one-lung anesthesia. Anesthesiology. 1987;67(5):841–4.

    Article  CAS  Google Scholar 

  30. Bakaeen F, Rice D, Correa AM, Walsh GL, Vaporciyan AA, Putnam JB, et al. Use of aprotinin in extrapleural pneumonectomy: effect on hemostasis and incidence of complications. Ann Thorac Surg. 2007;84(3):982–6.

    Article  Google Scholar 

  31. Slinger PD. Perioperative fluid management for thoracic surgery: the puzzle of postpneumonectomy pulmonary edema. J Cardiothorac Vasc Anesth. 1995;9(4):442–51.

    Article  CAS  Google Scholar 

  32. Schipper PH, Nichols FC, Thomse KM, Deschamps C, Cassivi SD, Allen MS, et al. Malignant pleural mesothelioma: surgical management in 285 patients. Ann Thorac Surg. 2008;85(1):257–64.

    Article  Google Scholar 

  33. Stewart DJ, Martin-Ucar AE, Edwards JG, West K, Waller DA. Extra-pleural pneumonectomy for malignant pleural mesothelioma: the risks of induction chemotherapy, right-sided procedures and prolonged operations. Eur J Cardiothorac Surg. 2005;27(3):373–8.

    Article  Google Scholar 

  34. de Perrot M, McRae K, Anraku M, Karkouti K, Waddell TK, Pierre AF, et al. Risk factors for major complications after extrapleural pneumonectomy for malignant pleural mesothelioma. Ann Thorac Surg. 2008;85(4):1206–10.

    Article  Google Scholar 

  35. Passman RS, Gingold DS, Amar D, Lloyd-Jones D, Bennett CL, Zhang H, et al. Prediction rule for atrial fibrillation after major noncardiac thoracic surgery. Ann Thorac Surg. 2005;79(5):1698–703.

    Article  Google Scholar 

  36. Roselli EE, Murthy SC, Rice TW, Houghtaling PL, Pierce CD, Karchmer DP, et al. Atrial fibrillation complicating lung cancer resection. J Thorac Cardiovasc Surg. 2005;130(2):438–44.

    Article  Google Scholar 

  37. Frendl G, Sodickson AC, Chung MK, Waldo AL, Gersh BJ, Tisdale JE, et al. 2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures. Executive summary. J Thorac Cardiovasc Surg. 2014;148(3):772–91.

    Article  Google Scholar 

  38. Brown MJ, Brown DR. Thoracic cavity irrigation: an unusual cause of acute ST segment increase. Anesth Analg. 2002;95(3):552–4, table of contents.

    PubMed  Google Scholar 

  39. Obata H, Saito S, Fujita N, Fuse Y, Ishizaki K, Goto F. Epidural block with mepivacaine before surgery reduces long-term post-thoracotomy pain. Can J Anaesth. 1999;46(12):1127–32.

    Article  CAS  Google Scholar 

  40. Senturk M, Ozcan PE, Talu GK, Kiyan E, Camci E, Ozyalcin S, et al. The effects of three different analgesia techniques on long-term postthoracotomy pain. Anesth Analg. 2002;94(1):11–5, table of contents.

    Article  Google Scholar 

  41. Suzuki M, Haraguti S, Sugimoto K, Kikutani T, Shimada Y. Sakamoto A. Low-dose intravenous ketamine potentiates epidural analgesia after thoracotomy. Anesthesiology. 2006;105(1):111–9.

    Article  CAS  Google Scholar 

  42. Wolf AS, Daniel J, Sugarbaker DJ. Surgical techniques for multimodality treatment of malignant pleural mesothelioma: extrapleural pneumonectomy and pleurectomy/decortication. Semin Thorac Cardiovasc Surg. 2009;21(2):132–48.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ju-Mei Ng .

Editor information

Editors and Affiliations

Clinical Case Discussion

Clinical Case Discussion

Case

A 50 year-old male is scheduled for right extrapleural pneumonectomy. The diagnosis of mesothelioma was made on pleural biopsy, and he has completed six cycles of chemotherapy. He is a nonsmoker, and apart from well-controlled hypertension, he has no other significant comorbidities.

Questions

  1. 1.

    Apart from routine preoperative assessment for pulmonary resection:

    1. (a)

      Are any specialized cardiac and pulmonary function tests indicated?

      • Echocardiography commonly used to assess cardiac function.

      • Stress test only when history, examination, and echocardiography suggest significant cardiac disease.

      • FEV1, DLCO, and exercise capacity routinely assessed.

      • Ventilation/perfusion scans recommended if FEV1 < 2 L.

      • Predicted postoperative FEV1 < 1 L may preclude EPP.

    2. (b)

      What is the importance of radiologic investigations?

      • Surgical staging and tumor resectability.

      • Anesthetic implications include safe placement of epidural catheters at the thoracic region, level of intravenous access, quantity of blood and blood products available, and the potential necessity for cardiopulmonary bypass during resection.

  2. 2.

    How is an extrapleural pneumonectomy different from pneumonectomy?

  3. 3.

    What are the common causes of hypotension and the management strategies? (Table 36.5)

  4. 4.

    How would the application of intraoperative intracavitary heated chemotherapy affect the anesthetic management?

    • Renal protective strategies should be employed (Table 36.1).

    • Restrictive physiology exhibited by EPP patients during one-lung ventilation is exacerbated by the weight of the perfusate, and positive end-expiratory pressure is especially important to prevent atelectasis.

    • Fluid management is delicate balance between renal protection and the potential for exacerbation of acute lung injury in fluid overload.

Table 36.5 Hypotension during critical phases of surgery

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Ng, JM. (2019). Extrapleural Pneumonectomy. In: Slinger, P. (eds) Principles and Practice of Anesthesia for Thoracic Surgery. Springer, Cham. https://doi.org/10.1007/978-3-030-00859-8_36

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-00859-8_36

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-00858-1

  • Online ISBN: 978-3-030-00859-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics